Related Experiment Videos
Sensitivity of intracellular bacteriophage lambda to colicin CA42-E2.
Journal of Virology
|October 1, 1971
Summary
Colicin CA42-E2 partially inhibits lambda phage infection in Escherichia coli. While colicin kills uninfected bacteria, it degrades lambda phage DNA in infected cells, indicating a protective effect against colicin in infected bacteria.
Area of Science:
- Microbiology
- Molecular Biology
- Bacteriology
Background:
- Colicins are bacteriocins produced by bacteria that inhibit or kill competing bacterial species.
- Bacteriophage lambda is a temperate bacteriophage that infects Escherichia coli.
- Understanding the interaction between colicins and bacteriophages is crucial for microbial control strategies.
Purpose of the Study:
- To investigate the effect of colicin CA42-E2 on lambda CIts857-infected Escherichia coli K-12.
- To determine the mechanism of colicin action on both infected and uninfected bacterial cells.
- To analyze the impact of colicin on bacteriophage DNA within the host cell.
Main Methods:
- Treatment of Escherichia coli K-12 with colicin CA42-E2.
- Infection of E. coli with lambda CIts857 phage.
- Assay of bacterial plaque-forming ability.
- Analysis of bacterial DNA degradation using acid solubility tests.
- Identification of DNA breakdown intermediates.
Main Results:
- Colicin CA42-E2 partially inhibited the lambda phage infectious process in E. coli.
- Uninfected bacteria were killed by colicin at a significantly higher rate than lambda-infected bacteria.
- Lambda DNA, whether replicating or non-replicating, was degraded to acid-soluble material after colicin treatment.
- DNA degradation was preceded by endonucleolytic fragmentation, a mechanism consistent with colicin activity on chromosomal DNA.
Conclusions:
- Colicin CA42-E2 exhibits a partial protective effect against lambda phage infection in E. coli.
- The degradation of lambda DNA by colicin involves endonucleolytic fragmentation, similar to its effect on the bacterial chromosome.
- This study elucidates the complex interplay between colicin activity and bacteriophage infection in bacterial hosts.